Cochrane Common Mental Disorders assists in the production and maintenance of Cochrane reviews that assess the effects (including harm) of treatments in the prevention and management of a range of mental disorders.
Cochrane Dementia and Cognitive Improvement focuses on the prevention, treatment, and management of acute or chronic acquired cognitive impairments, their manifestations and complications, and the care of people affected. They also produce reviews on the enhancement of cognitive function in healthy adults and the diagnosis of dementia.
The Cochrane Developmental, Psychosocial and Learning Problems group target a range of medical, social, educational and socio-legal problems, including: developmental and psychosocial problems of childhood and adolescence; including juvenile delinquency; learning problems (including, but not restricted to, learning disabilities) across the lifespan; and personality disorders and adult offending. They also consider the effects of social and policy interventions, which impact on the development of children and adolescents (e.g., pre-school day care), although these may not be specifically targeted at an identified problem.
Cochrane Drugs and Alcohol focues mainly on Cochrane Reviews that describe an active intervention (including prevention, treatment and rehabilitation) aimed at reducing the potential for harm or the actual harm directly related to the use of different dependence producing substances.
Cochrane Epilepsy group focues on Cochrane Reviews that assess the outcomes (including harm) of interventions designed to prevent and manage childhood and adulthood seizures and epilepsy.
Cochrane Movement Disorders focus on conditions such as idiopathic Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and other akinetic-rigid syndromes, Huntington's disease, dystonia, tremor, and tic disorders.
Cochrane Multiple Sclerosis and Rare Diseases of the CNS aims to produce Cochrane Reviews on all aspects of the prevention, treatment, rehabilitation and palliative care of multiple sclerosis and interventions related to Rare Diseases of the CNS.
Cochrane Neuromuscular aims to cover interventions for the whole range of neuromuscular diseases and tests of diagnostic accuracy for neuromuscular disease.
Cochrane Schizophrenia is concerned with the evaluation of the prevention, treatment and rehabilitation of people with non-affective, functional, psychotic illnesses.